Algert Global LLC Ngm Biopharmaceuticals Inc Transaction History

Algert Global LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.05 - $3.37 $104,853 - $336,528	-99,860 Reduced 72.76%	37,390 $40,000
Q2 2023 Aug 14, 2023	SELL	$2.44 - $4.53 $36,624 - $67,995	-15,010 Reduced 9.86%	137,250 $355,000
Q1 2023 May 12, 2023	BUY	$3.72 - $5.4 $291,536 - $423,198	78,370 Added 106.06%	152,260 $621,000
Q4 2022 Feb 13, 2023	SELL	$3.41 - $12.93 $13,469 - $51,073	-3,950 Reduced 5.07%	73,890 $371,000
Q3 2022 Nov 15, 2022	BUY	$12.59 - $17.67 $73,991 - $103,846	5,877 Added 8.17%	77,840 $1.02 Million
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $455,469 - $753,375	43,050 Added 148.89%	71,963 $923,000
Q1 2022 May 16, 2022	BUY	$13.81 - $18.6 $114,167 - $153,766	8,267 Added 40.04%	28,913 $441,000
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $356,349 - $454,624	20,646 New	20,646 $366,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.